Why the study?
Does radiofrequency-based transperineal thermal prostate ablation (TTPA) improve clinical outcomes compared to single-fiber transperineal laser ablation (TPLA) in patients with symptomatic BPH?
Does radiofrequency-based transperineal thermal prostate ablation (TTPA) improve clinical outcomes compared to single-fiber transperineal laser ablation (TPLA) in patients with symptomatic BPH?
Radiofrequency-based ablation for BPH offers shorter procedure times with similar 12-month clinical efficacy compared to laser ablation, suggesting workflow advantages without compromising outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2026) conducted an editorial in Benign prostatic hyperplasia (BPH) (n=36). Radiofrequency-based transperineal thermal prostate ablation (TTPA) vs. Single-fiber transperineal laser ablation (TPLA) was evaluated on Clinical efficacy (International Prostate Symptom Score, quality of life, prostate volume, peak urinary flow, and post-void residual volume).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: